Cytokines' Impact on Postpartum Hair Loss After First C-Section in Women 28-38
Dampak Sitokin terhadap Kerontokan Rambut Pasca Persalinan Setelah Operasi Caesar Pertama pada Wanita 28-38
DOI:
https://doi.org/10.21070/ijhsm.v2i1.119Keywords:
Postpartum, Cesarean Delivery, Inflammatory Markers, Hair Loss, Metabolic Disturbances, Hormonal ChangesAbstract
Background; Postpartum hair loss is a common condition affecting women after childbirth, particularly in those who have undergone cesarean delivery. Cytokines, which are key regulators of immune responses, are believed to play a significant role in the pathogenesis of this condition by influencing the hair growth cycle and immune function during the postpartum period. Aims of the study; Investigate the role of cytokines, including IL-6, TNF-α, IL-10, and CRP, in postpartum hair loss in women aged 28-38 after their first cesarean delivery, and to explore their potential correlation with changes in thyroid function and lipid profiles during the postpartum period. Methodology; This cross-sectional study aimed to determine biomarker levels in women aged 28-38 after their first cesarean section. It included 150 participants: 100 women post-first cesarean and 50 healthy controls. Ethical approval was obtained, and informed consent was given by all participants. Exclusion criteria included multiple cesarean sections, chronic diseases, or medication affecting biomarkers. Blood samples were collected after an overnight fast, and biomarkers like IL-6, TNF-α, IL-10, CRP, adiponectin, FBS, lipid profile, TSH, and Free T3 were measured using appropriate assays. Statistical analysis was performed, with p < 0.05 considered significant. Result; The comparative results between patients (n=100) and healthy controls (n=50) showed no significant difference in age (33.5 ± 3.4 vs. 30.2 ± 3.1 years, p=0.12). However, patients had a significantly higher BMI (29.5 ± 3.2 kg/m²) compared to controls (26.1 ± 3.0 kg/m², p<0.001). Levels of inflammatory markers (IL-6, TNF-α, IL-10, CRP) were significantly higher in patients (p<0.001), while adiponectin levels were lower (14.2 ± 7.5 ng/mL vs. 20.8 ± 9.1 ng/mL, p=0.02). Metabolic markers such as fasting blood sugar, cholesterol, triglycerides, and LDL-C were significantly elevated in patients (p<0.001). The severity of hair loss was also greater in patients (p<0.001). Additionally, TSH levels were significantly higher in patients (p=0.02), while Free T3 showed no significant difference (p=0.12). Conclusions; In conclusion, elevated inflammatory markers (IL-6, TNF-α, IL-10) and metabolic disturbances (higher BMI, fasting blood sugar, cholesterol) in postpartum women after cesarean delivery may contribute to hair loss. These alterations reflect the body's response to stress and hormonal changes following delivery.
Highlights:
- Inflammatory Response & Hair Loss – Elevated levels of IL-6, TNF-α, IL-10, and CRP in postpartum women after cesarean delivery suggest a strong link between inflammation and hair loss.
- Metabolic & Hormonal Changes – Higher BMI, increased fasting blood sugar, cholesterol, and TSH levels indicate metabolic disturbances that may contribute to postpartum hair loss.
- Clinical Implications – Understanding these biomarker changes could help in developing targeted interventions to manage postpartum hair loss and associated metabolic risks.
Keyword: Postpartum, Cesarean Delivery, Inflammatory Markers, Hair Loss, Metabolic Disturbances, Hormonal Changes
References
[1] K. Ansari, et al., "Investigating the Prevalence of Postpartum Hair Loss and Its Associated Risk Factors: A Cross-Sectional Study," Iranian Journal of Dermatology, vol. 24, no. 4, pp. 295-299, 2021.
[2] S. A. Galal, S. K. El-Sayed, and M. M. H. Henidy, "Postpartum Telogen Effluvium Unmasking Additional Latent Hair Loss Disorders," The Journal of Clinical and Aesthetic Dermatology, vol. 17, no. 5, p. 15, 2024.
[3] C. Liu, et al., "Cytokines: From Clinical Significance to Quantification," Advanced Science, vol. 8, no. 15, p. 2004433, 2021.
[4] E. Szendzielorz and R. Spiewak, "Placental Extracts, Proteins, and Hydrolyzed Proteins as Active Ingredients in Cosmetic Preparations for Hair Loss: A Systematic Review of Available Clinical Evidence," Applied Sciences, vol. 14, no. 22, p. 10301, 2024.
[5] M. J. Anzelc and M. A. Bechtel, "Considerations for Cutaneous Physiologic Changes of Pregnancy That Fail to Resolve Postpartum," International Journal of Dermatology, vol. 62, no. 2, pp. 190-196, 2023.
[6] I. Leites, et al., "Seasonal Chronic Heat Stress, Body Temperatures, Metabolic Profiles, Hair Cortisol Concentrations, and Uterine Immune Cell Populations in Postpartum Dairy Cows," unpublished.
[7] D. Lateef, N. Nasser, and O. Mohsein, "The Relationships Between Aplein, Vaspin and Thyroid Hormone Levels in Obese Diabetic and Non-Diabetic Women," Journal of Experimental and Clinical Medicine, vol. 41, no. 2, pp. 239-245, 2024.
[8] H. S. Abd-Alwahab, Z. M. Farhan, and N. Ahmed, "Estimation of Thyroid Hormone and Adipocytokine Levels in Men With Obesity and Type 2 Diabetes in Thi-Qar Governorate," unpublished.
[9] A. N. Faisal, et al., "Histological and Cytokine-Based Biomarkers in the Early Diagnosis of Cancer," Indonesian Journal on Health Science and Medicine, vol. 2, no. 2, pp. 10-21070, 2025.
[10] C. Affortit, et al., "A Disease-Associated Mutation in Thyroid Hormone Receptor α1 Causes Hearing Loss and Sensory Hair Cell Patterning Defects in Mice," Science Signaling, vol. 15, no. 738, p. eabj4583, 2022.
[11] S. Torkestani, et al., "Evaluation of Serum Levels of IL-6, IL-10, and TNF-Alpha in Alopecia Areata Patients: A Systematic Review and Meta-Analysis," Biomedical Research and Therapy, vol. 8, no. 10, pp. 4668-4678, 2021.
[12] S. Koç Yıldırım, E. Erbağcı, and N. D. Öğüt, "Evaluation of Patients With Telogen Effluvium During the Pandemic: May the Monocytes Be Responsible for Post COVID-19 Telogen Effluvium?," Journal of Cosmetic Dermatology, vol. 21, no. 5, pp. 1809-1815, 2022.
[13] T. Yuksek, et al., "Elucidating the Role of T-Reg Related Cytokines: Serum Transforming Growth Factor Beta and Interleukin-35 in Alopecia Areata," Archives of Dermatological Research, vol. 316, no. 6, p. 205, 2024.
[14] B. N. Kalaycı and İ. Balta, "Evaluation of the Serum C-Reactive Protein–Albumin Ratio and Its Relationship With Disease Severity in Alopecia Areata: A Prospective Case-Control Study," Journal of Cosmetic Dermatology, vol. 21, no. 12, pp. 7194-7199, 2022.
[15] C. Nicu, et al., "Adiponectin Negatively Regulates Pigmentation, Wnt/β-Catenin and HGF/c-Met Signalling Within Human Scalp Hair Follicles Ex Vivo," Archives of Dermatological Research, vol. 315, no. 3, pp. 603-612, 2023.
[16] C. J. G. Cruz, et al., "Adipose Transcriptome in the Scalp of Androgenetic Alopecia," Frontiers in Medicine, vol. 10, p. 1195656, 2023.
[17] S. B. Dayel, et al., "Is Thyroid Dysfunction a Common Cause of Telogen Effluvium?: A Retrospective Study," Medicine, vol. 103, no. 1, p. e36803, 2024.
[18] A. A. H. Al-Nakash and Y. A. Raheem, "Serum Ferritin and Body Mass Index in Chronic Telogen Effluvium Among Women Attending the Main Dermatological Outpatient Clinics in Baghdad," AL-Kindy College Medical Journal, vol. 16, no. 1, pp. 102-109, 2020.
[19] I. H. Yavuz, et al., "Assessment of Heavy Metal and Trace Element Levels in Patients With Telogen Effluvium," Indian Journal of Dermatology, vol. 63, no. 3, pp. 246-250, 2018.
[20] G. Battineni, et al., "Impact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD)," International Journal of Molecular Sciences, vol. 22, no. 9, p. 4798, 2021.
[21] S. Wang and J. Ren, "Obesity Paradox in Aging: From Prevalence to Pathophysiology," Progress in Cardiovascular Diseases, vol. 61, no. 2, pp. 182-189, 2018.
[22] A. Hirose, et al., "Investigation of Exacerbating Factors for Postpartum Hair Loss: A Questionnaire-Based Cross-Sectional Study," International Journal of Women's Dermatology, vol. 9, no. 2, p. e084, 2023.
[23] K. Ansari, et al., "Investigating the Prevalence of Postpartum Hair Loss and Its Associated Risk Factors: A Cross-Sectional Study," Iranian Journal of Dermatology, vol. 24, no. 4, pp. 295-299, 2021.
[24] F. Rebelo, et al., "Plasma and Breast Milk Adipokines in Women Across the First Year Postpartum and Their Association With Maternal Depressive Symptoms and Infant Neurodevelopment: Protocol for the APPLE Prospective Cohort Study," PLOS One, vol. 19, no. 10, p. e0310847, 2024.
[25] C. R. Schneider et al., "Associations of Neonatal Adiponectin and Leptin With Growth and Body Composition in African American Infants," Pediatr. Obes., vol. 13, no. 8, pp. 485–491, 2018.
[26] M. S. Najafabadi et al., "A Comparison of the Portfolio Low-Carbohydrate Diet and the Ketogenic Diet in Overweight and Obese Women With Polycystic Ovary Syndrome: Study Protocol for a Randomized Controlled Trial," Trials, vol. 24, no. 1, p. 509, 2023.
[27] M. E. Khamseh et al., "Guideline for the Diagnosis and Treatment of Diabetes Mellitus in Patients With Transfusion-Dependent Thalassemia," Iran. J. Blood Cancer, vol. 15, no. 4, pp. 293–303, 2023.
[28] A. Balkrishna et al., "Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management," Evid.-Based Complement. Altern. Med., vol. 2023, no. 1, p. 3705508, 2023.
[29] A. Hirose et al., "Investigation of Exacerbating Factors for Postpartum Hair Loss: A Questionnaire-Based Cross-Sectional Study," Int. J. Women's Dermatol., vol. 9, no. 2, p. e084, 2023.
[30] K. Ansari et al., "Investigating the Prevalence of Postpartum Hair Loss and Its Associated Risk Factors: A Cross-Sectional Study," Iran. J. Dermatol., vol. 24, no. 4, pp. 295–299, 2021.
[31] F. Yousefian, S. Yadlapati, and J. Krejci-Manwaring, "Postpartum Alopecia," J. Case Rep. Med. Hist., vol. 2, no. 5, 2022.
[32] L. Jahangard et al., "Prenatal and Postnatal Hair Steroid Levels Predict Postpartum Depression 12 Weeks After Delivery," J. Clin. Med., vol. 8, no. 9, p. 1290, 2019.
[33] F. Nematulloeva and Z. Wang, "Evaluation of Puerperal and Postpartum Infections After Cesarean Section and Their Clinical Outcomes," Open J. Intern. Med., vol. 13, no. 4, pp. 330–350, 2023.
[34] M. Grymowicz et al., "Hormonal Effects on Hair Follicles," Int. J. Mol. Sci., vol. 21, no. 15, p. 5342, 2020.
[35] M. J. Anzelc and M. A. Bechtel, "Considerations for Cutaneous Physiologic Changes of Pregnancy That Fail to Resolve Postpartum," Int. J. Dermatol., vol. 62, no. 2, pp. 190–196, 2023.
[36] F. M. Brenner and C. Oldoni, "Telogen Effluvium vs. Female Pattern Hair Loss: Is There a Correlation?," An. Bras. Dermatol., vol. 94, no. 4, pp. 486–487, 2019.
[37] R. Hasan et al., "Effects of Hormones and Endocrine Disorders on Hair Growth," Cureus, vol. 14, no. 12, 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indonesian Journal on Health Science and Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
